These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7719082)

  • 1. [Motility disorders in brachytherapy of choroid melanomas with Ru106 applicators].
    Langmann A; Langmann G; Unlücerci C; Haller E
    Ophthalmologe; 1995 Feb; 92(1):76-8. PubMed ID: 7719082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
    Toivonen P; Kivelä T
    Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Criteria for assessing the efficacy of brachytherapy of uveal melanomas, complications of therapy and there prevention].
    Brovkina AF; Zarubeí GD; Val'skií VV
    Vestn Oftalmol; 1997; 113(3):14-6. PubMed ID: 9265351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of radiation resistant malignant uveal melanoma with endoresection by pars plana vitrectomy in two patients].
    Schmidt JC; Brieden-Azvedo S; Nietgen GW
    Klin Monbl Augenheilkd; 2001 Dec; 218(12):800-4. PubMed ID: 11805872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term results of cobalt 60 curietherapy for uveal melanoma].
    Bacin F; Kwiatkowski F; Dalens H; Rozan R; Gagyi S; Donnarieix D; Bard JJ; Robert JL
    J Fr Ophtalmol; 1998 May; 21(5):333-44. PubMed ID: 9759427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of 100 melanomas of the choroid and ciliary body treated by application of ruthenium (RU 106 Rh 106)].
    Grange JD; Gerard JP; Ragab M; Quintero P; Delaroche G; Jean-Louis B; Sentenac I; Fontaniere B; Bievelez B
    Bull Soc Ophtalmol Fr; 1989 May; 89(5):679-82. PubMed ID: 2590984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiation optic neuropathy after the brachytherapy of the uveal melanoma].
    Szuścik I; Romanowska-Dixon B; Markiewicz A; Pogrzebielski A; Jakubowska B
    Klin Oczna; 2006; 108(7-9):278-80. PubMed ID: 17290823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plexiglass replicas for optimizing selection and site of ruthenium 106 applicators].
    Menapace R
    Klin Monbl Augenheilkd; 1990 Jan; 196(1):40-2. PubMed ID: 2313993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruthenium applicators in the treatment of choroidal melanomas.
    Van Hijfte R; Verbraeken H; De Laey JJ
    Bull Soc Belge Ophtalmol; 1987; 224():51-8. PubMed ID: 3509023
    [No Abstract]   [Full Text] [Related]  

  • 11. Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas.
    Damato B; Patel I; Campbell IR; Mayles HM; Errington RD
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):392-400. PubMed ID: 15990248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extraocular muscle repositioning and diplopia: associated with ophthalmic plaque radiation therapy for choroidal melanoma.
    Nagendran ST; Finger PT; Campolattaro BN
    Ophthalmology; 2014 Nov; 121(11):2268-74. PubMed ID: 25062940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular motility disturbances after episcleral plaque brachytherapy for uveal melanoma.
    Sener EC; Kiratli H; Gedik S; Sanac AS
    J AAPOS; 2004 Feb; 8(1):38-45. PubMed ID: 14970798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indocyanine green angiography versus fluorescein angiography in the follow-up of choroidal melanomas treated with RU106/RH106.
    Sallet G; Amoaku WM; Lafaut BA; Van Liefferinge B; De Laey JJ
    Bull Soc Belge Ophtalmol; 1996; 263():27-37. PubMed ID: 9396191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27.
    Collaborative Ocular Melanoma Study Group
    Ophthalmology; 2007 Jul; 114(7):1363-71. PubMed ID: 17337065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ruthenium-106 brachytherapy for choroidal melanoma without transpupillary thermotherapy: Similar efficacy with improved visual outcome.
    Marinkovic M; Horeweg N; Fiocco M; Peters FP; Sommers LW; Laman MS; Bleeker JC; Ketelaars M; Luyten GP; Creutzberg CL
    Eur J Cancer; 2016 Nov; 68():106-113. PubMed ID: 27741435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strabismus in adults with uveal melanoma following episcleral plaque brachytherapy.
    Dawson E; Sagoo MS; Mehta JS; Comer R; Hungerford J; Lee J
    J AAPOS; 2007 Dec; 11(6):584-8. PubMed ID: 17588793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation complications and tumor control after 125I plaque brachytherapy for ocular melanoma.
    Jensen AW; Petersen IA; Kline RW; Stafford SL; Schomberg PJ; Robertson DM
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):101-8. PubMed ID: 16111577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant melanomas of the choroid and ruthenium applicators.
    Huyghe JP; Verbraeken H; Goes F; De Wilde G; Hanssens M; Brabant P; Van Hijfte R; De Laey JJ
    Bull Soc Belge Ophtalmol; 1990; 238():137-43. PubMed ID: 2131116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.